Marpai, Inc. Issues \$250,000 Promissory Note to CEO: Key Details for Investors

Summary of Material Event

On March 9, 2026, Marpai, Inc. (OTCQX: MRAI), an emerging growth company specializing in healthcare technology, disclosed that it has entered into a material definitive agreement involving the issuance of a promissory note in the principal amount of \$250,000 to its Chief Executive Officer, Damien Lamendola.

Details of the Promissory Note

• Principal Amount: \$250,000
• Interest Rate: 12.0% per annum, or the maximum amount allowed by New York law, whichever is less
• Maturity Date: All principal, accrued interest, and any other amounts due are payable by May 10, 2026
• Prepayment: Marpai, Inc. may prepay the note, in whole or in part, at any time without premium or penalty, including all accrued interest and any other sums due
• Use of Proceeds: The company will use the funds for general working capital purposes
• Holder: Damien Lamendola, CEO (or his successors and assigns)

Corporate Governance and Transparency

This transaction is noteworthy as it involves a direct financial arrangement between the company and its CEO. Such insider financing arrangements can be significant for investors, as they may indicate the company’s immediate liquidity needs, confidence in management, or potential risks associated with cash flow and operational financing.

Potential Impact on Shareholders

• Liquidity and Solvency: The need for working capital financing from the CEO may signal cash flow pressures or a lack of access to external funding. This is potentially price sensitive and could affect investor sentiment regarding the company’s financial health.
• Insider Confidence: Conversely, the CEO’s willingness to provide financing could be interpreted as a sign of confidence in the business and its near-term prospects, which may be viewed positively by some investors.
• Short-Term Repayment: The note is set to mature in just two months, suggesting a tight timeline for repayment and potentially highlighting the urgency of the company’s capital needs.
• Interest Rate: The relatively high interest rate (12%) is notable and may reflect perceived risk or limited access to lower-cost capital.

Other Relevant SEC Disclosures

• Emerging Growth Company: Marpai, Inc. is classified as an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards. This means the company must adopt new standards as they are issued, which can affect future financial reporting.
• Shares and Trading: The company’s primary security is Class A Common Stock, par value \$0.0001 per share, traded under the symbol MRAI on the OTCQX Market.
• No Pre-commencement or Soliciting Material: The filing confirms that there are no written communications, soliciting materials, or pre-commencement tender offers associated with this report.

Summary for Investors

The issuance of a \$250,000 promissory note to the CEO of Marpai, Inc. is a material event that may have implications for the company’s liquidity, governance, and short-term financial strategy. Investors should monitor subsequent filings for any updates regarding repayment, additional financing needs, or changes in the company’s capital structure. The short-term nature of the note and the involvement of a senior executive could be interpreted as either a sign of confidence or concern, depending on the broader context of Marpai’s operations and financial health.

Disclaimer: The information provided above is for informational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence and consult with financial advisors before making any investment decisions. The details are based on public SEC filings as of March 9, 2026, and may be subject to change.

View Marpai, Inc. Historical chart here